Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06355830

Intermediate Age-related Macular Degeneration - Multimodal Analysis and Longitudinal Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Universidade Nova de Lisboa · Academic / Other
Sex
All
Age
55 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Study: observational prospective clinical study. Study population: Subjects over 55 years old with drusen secondary to intermediate AMD. Recruitment: at the Medical Retinal Consultation from the Ophthalmology Department of CHULC. Primary outcome: Identifying imaging predictors of iAMD progression.

Detailed description

Individuals will be included consecutively and undergo retinal imaging including Color Fundus photography (CFP), Spectral Domain Optical Coherence Tomography (SD-OCT), OCT-Angiography (OCT-A) using Spectralis OCT, with OCT Angiography Module (Heidelberg Eng. GmbH, Germany), in order to characterize: A. FUNDUS AUTOFLUORESCENCE 1. Analyse the correlation between drusen morphology and autofluorescent findings 2. Analyse the correlation between outer retinal layers morphology and autofluorescent findings 3. Assess anatomic biomarkers of disease progression B. VASCULAR FINDINGS 1. Test if choriocapillaris perfusion is disturbed in Intermediate AMD patients; 2. Test if retinal capillary plexus perfusion is disturbed in Intermediate AMD patients: 2.1. Analyze superficial retinal capillary plexus (SCP), 2.2. Analyze deep retinal capillary plexus (DCP); 3. Assess if choroidal and retinal vascular changes are related to disease progression.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOrthoptic assessment (Outcome measure)The protocol image assessment is non-invasive and includes retinal imaging by Color Fundus photography (CFP), Spectral Domain Optical Coherence Tomography (SD-OCT), OCT-Angiography (OCT-A) using Spectralis OCT, with OCT Angiography Module (Heidelberg Eng. GmbH, Germany).

Timeline

Start date
2019-01-02
Primary completion
2025-06-01
Completion
2026-06-01
First posted
2024-04-09
Last updated
2024-04-09

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT06355830. Inclusion in this directory is not an endorsement.